Arecor Therapeutics plc announced that, due to its auditor, Grant Thornton UK LLP, requiring additional time to complete its standard procedures, the Group's final results for the year ended 31 December 2023 will not be published on 7 May 2024, the previously planned date. The Group will now announce its results in the week commencing 13 May 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159 GBX | +0.95% | +0.32% | -12.88% |
05-21 | Transcript : Arecor Therapeutics plc - Special Call | |
05-20 | Arecor Therapeutics plc Announces Its Ultra-Concentrated, Ultra-Rapid Acting Insulins | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.88% | 61.96M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- AREC Stock
- News Arecor Therapeutics plc
- Arecor Therapeutics plc Announces Delay in Publication of the Group's Final Results for the Year Ended 31 December 2023